Is incentivising stroke prevention therapy in atrial fibrillation the key?
- PMID: 29991505
- DOI: 10.1136/heartjnl-2018-313402
Is incentivising stroke prevention therapy in atrial fibrillation the key?
Keywords: atrial fibrillation.
Conflict of interest statement
Competing interests: JAE has received research support and honoraria from BMS/Pfizer and Bayer related to oral anticoagulation in patients with atrial fibrillation and served on the Steering Committee for ARISTOTLE. RKS has no relevant disclosures.
Comment on
-
Prevalence and treatment of atrial fibrillation in UK general practice from 2000 to 2016.Heart. 2019 Jan;105(1):27-33. doi: 10.1136/heartjnl-2018-312977. Epub 2018 Jul 10. Heart. 2019. PMID: 29991504
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical